HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zbigniew M Szczepiorkowski Selected Research

Ambar

10/2023Impact of therapeutic and low volume plasma exchange on clinical laboratory parameters in patients treated for Alzheimer's disease from the AMBAR study.
2/2023Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study.
1/2022Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
10/2020A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
1/2019Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zbigniew M Szczepiorkowski Research Topics

Disease

5Alzheimer Disease (Alzheimer's Disease)
10/2023 - 01/2019
5Thrombocytopenia (Thrombopenia)
06/2018 - 10/2013
4Hemorrhage
10/2020 - 11/2005
4Thrombotic Thrombocytopenic Purpura
06/2018 - 06/2010
4Neoplasms (Cancer)
05/2011 - 01/2007
3Graft vs Host Disease (Graft-Versus-Host Disease)
06/2018 - 01/2015
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2018 - 01/2015
2COVID-19
01/2022 - 01/2021
2Fever (Fevers)
06/2018 - 01/2018
2Acute Kidney Injury (Acute Renal Failure)
06/2018 - 10/2013
2Hemolytic Anemia
06/2018 - 12/2017
2Thrombosis (Thrombus)
06/2018 - 10/2013
2Anemia
08/2017 - 11/2005
2Parasitemia
08/2017 - 01/2014
2Renal Cell Carcinoma (Grawitz Tumor)
08/2009 - 01/2007
2Erythropoietic Protoporphyria
02/2005 - 03/2002
1Peritonitis
03/2024
1Fibrosis (Cirrhosis)
03/2024
1Fetomaternal Transfusion
01/2023
1Wounds and Injuries (Trauma)
10/2020
1Infections
01/2018
1Headache (Headaches)
01/2018
1Chills
01/2018
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2017
1Pneumonia (Pneumonitis)
12/2017
1Hemolysis
12/2017
1Babesiosis (Piroplasmosis)
08/2017
1Nervous System Paraneoplastic Syndromes
02/2016
1Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
02/2016
1Bronchiolitis Obliterans Syndrome
12/2015
1Lymphoma (Lymphomas)
01/2015
1Polymyositis
12/2014
1Sensorineural Hearing Loss
12/2014
1Myasthenia Gravis
12/2014
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
12/2014
1Neuromyelitis Optica (Devic's Disease)
12/2014
1Encephalitis (Encephalitis, Rasmussen)
12/2014
1Relapsing-Remitting Multiple Sclerosis
12/2014
1Malaria
01/2014
1Venous Thromboembolism
10/2013
1Pulmonary Embolism
10/2013
1Gangrene
10/2013
1Hemolytic-Uremic Syndrome
01/2012
1Glioblastoma (Glioblastoma Multiforme)
05/2011
1Diarrhea
12/2010
1Pancreatitis
05/2009
1Hypertriglyceridemia
05/2009
1Menorrhagia
01/2009

Drug/Important Bio-Agent (IBA)

5AlbuminsIBA
03/2024 - 01/2019
5AmbarIBA
10/2023 - 01/2019
3thiamine triphosphorate (TTP)IBA
06/2018 - 06/2014
3CytokinesIBA
08/2017 - 01/2007
3Interleukin-2 (IL2)IBA
12/2010 - 01/2007
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
10/2020 - 01/2018
2AntibodiesIBA
12/2017 - 02/2016
2VaccinesIBA
08/2009 - 01/2007
2Heme (Haem)IBA
02/2005 - 03/2002
1Rho(D) Immune Globulin (RhoGAM)IBA
01/2023
1WastewaterIBA
01/2022
1Viral RNAIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2019
1Amyloid (Amyloid Fibrils)IBA
01/2019
1Nucleic AcidsIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Ribosomal RNAIBA
01/2018
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2018
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
12/2017
1BilirubinIBA
08/2017
1SteroidsIBA
02/2016
1AutoantibodiesIBA
02/2016
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
02/2016
1Fibrinogen (Factor I)FDA Link
12/2014
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2014
1Phosphotransferases (Kinase)IBA
12/2014
1N-Methylaspartate (NMDA)IBA
12/2014
1Intravenous Immunoglobulins (IVIG)FDA Link
12/2014
1Rituximab (Mabthera)FDA Link
10/2013
1Heparin (Liquaemin)FDA LinkGeneric
10/2013
1InterferonsIBA
05/2011
1Temozolomide (Temodar)FDA LinkGeneric
05/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2010
1Troponin T (Troponin T1)IBA
06/2010
1InterleukinsIBA
08/2009
1aldesleukin (Proleukin)FDA Link
08/2009
1Cancer VaccinesIBA
01/2007
1polymerized bovine hemoglobinIBA
11/2005
1Oxygen (Dioxygen)IBA
11/2005

Therapy/Procedure

11Plasma Exchange
10/2023 - 05/2009
8Therapeutics
06/2018 - 01/2007
5Photopheresis
06/2018 - 12/2014
4Blood Component Removal (Apheresis)
08/2017 - 01/2014
3Drug Therapy (Chemotherapy)
12/2017 - 11/2005
1Renal Replacement Therapy (Therapies, Renal Replacement)
03/2024
1Critical Care (Surgical Intensive Care)
03/2024
1Activities of Daily Living (ADL)
10/2020
1Aftercare (After-Treatment)
01/2019
1Radiotherapy
05/2011
1Platelet Transfusion (Blood Platelet Transfusions)
02/2009
1Uterine Artery Embolization
01/2009